[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Pages 63432-63433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17220]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Healthcare Infection Control Practices Advisory 
Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention announces the following 
meeting for the Healthcare Infection Control Practices Advisory 
Committee (HICPAC). This virtual meeting is open to the public, limited 
only by the number of audio and web conference lines (500 audio and web 
conference lines are available). Time will be available for public 
comment.

DATES: The meeting will be held on August 22, 2024, from 9 a.m. to 5 
p.m., EDT.

ADDRESSES: The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the HICPAC website: https://www.cdc.gov/hicpac/meeting.html.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Committee 
Management Specialist, Healthcare Infection Control Practices Advisory 
Committee, Division of Healthcare Quality Promotion, National Center 
for Emerging and Zoonotic Infectious Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, 
Georgia 30329-4027. Telephone: (404) 718-8039; Email: [email protected].

SUPPLEMENTARY INFORMATION: 

[[Page 63433]]

    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Department of Health and Human Services, regarding (1) the practice of 
healthcare infection prevention and control; (2) strategies for 
surveillance, prevention, and control of infections, antimicrobial 
resistance, and related events in settings where healthcare is 
provided; and (3) periodic updating of CDC guidelines and other policy 
statements regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters to be Considered: The agenda will include the following 
updates: The Healthcare Personnel Guideline Workgroup; Isolation 
Precautions Guideline Workgroup; Dental Unit Waterlines Guideline 
Update; Division of Health Quality Promotion Updates; Review of Viral 
Hemorrhagic Fever Update; Pathogen Reduction Guidance Introduction; 
NHSN Update; Recommendation Categorization Framework Update. Agenda 
items are subject to change.

Public Participation

    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Priority will be given to 
individuals who submit a request to make an oral public comment before 
the meeting according to the procedures below. All persons interested 
in making an oral public comment at the August 22, 2024 HICPAC meeting 
must submit a request between July 26, 2024, and August 12, 2024, at 
https://www.cdc.gov/hicpac/meeting.html no later than 11:59 p.m., EDT, 
August 12, 2024, according to the instructions provided on the HICPAC 
website. If the number of persons requesting to speak is greater than 
can be reasonably accommodated during the scheduled time, CDC will 
conduct a lottery to determine the speakers for the scheduled public 
comment session. CDC staff will notify individuals regarding their 
request to speak by email by August 17, 2024.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-17220 Filed 8-2-24; 8:45 am]
BILLING CODE 4163-18-P